Hypolipidemic effect of Goami-3 rice (Oryza sativa L. cv. Goami-3) on C57BL/6J mice is mediated by the regulation of peroxisome proliferator-activated receptor-α and -γ

Journal of Nutritional Biochemistry

Volumn 24, Issue 11, 2013, Pages 1991-2000

  Lee, A Young ^a   Yeo, Siok Koon ^b   Lee, Ji Hae ^b   Kim, Hea won ^b   Jia, Yaoyao ^b   Hoang, Minh Hien ^b   Chung, Hyun ^a   Kim, Young Suk ^a   Lee, Sung Joon ^b  

^a Ewha Womans University   (South Korea)

^b Korea University   (South Korea)

Author keywords

GC TOF MS; Metabolic profiling; PPAR; Rice

Indexed keywords

ADIPONECTIN; CHOLESTEROL; FATTY ACID; FATTY ACID SYNTHASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; VALINE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; DIET; DYSLIPIDEMIA; GAS CHROMATOGRAPHY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GOAMI 3 RICE; HYDROLYSIS; HYPOLIPIDEMIC EFFECT; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID STORAGE; LIVER; LIVER CELL CULTURE; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RICE; TIME OF FLIGHT MASS SPECTROMETRY; TRANSACTIVATION;

MUS; ORYZA SATIVA;

GC-TOF-MS; METABOLIC PROFILING; PPAR; RICE;

ADIPOSE TISSUE; AMYLOSE; ANIMALS; CHOLESTEROL; DIET, HIGH-FAT; DIETARY FIBER; LEPTIN; LIPOPROTEINS, HDL; MALE; MICE; MICE, INBRED C57BL; OBESITY; ORYZA SATIVA; PPAR ALPHA; PPAR GAMMA; TRIGLYCERIDES;

EID: 84885836128     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.06.008     Document Type: Article

References (51)

1. Coenen K.R., Hasty A.H. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis in high fat diet-fed Agouti LDLR deficient mice. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E492-E499.
2. Rosen E.D., Hsu C.H., Wang X., Sakai S., Freeman M.W., Gonzalez F.J., et al. C/EBPa induces adipogenesis through PPARg: a unified pathway. Genes Dev. 2002, 16:22-26.
3. Smith S.A. Peroxisomal proliferate-activated receptors and the regulation of lipid oxidation and adipogenesis. Biochem Soc Trans. 1997, 25:1242-1248.
4. Memon R.A., Tecott L.H., Nonogaki K., Beigneux A., Moser A.H., Grunfeld C., et al. Up-regulation of peroxisome proliferator-activated receptors (PPAR-α) and PPAR-γ messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-γ-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinol. 2000, 141:4021-4031.
5. Fruchart J.C. Peroxisome proliferator-activated receptor-alpha (PPARalpha): at the crossroads of obesity, diabetes and cardiovascular disease. Atherosclerosis 2009, 205(1):1-8.
6. Schoonjans K., Staels B., Auwerx J. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta. 1996, 1302:93-109.
7. Jun H., Daiwen C., Bing Y. Metabolic and transcriptomic responses of weaned pigs induced by different dietary amylose and amylopectin ratio. PLoS One 2010, 5(11):e15110.
8. Miller J.B., Pang E., Bramall L. Rice: a high or low glycemic index food?. Am. J. Clin. Nutr. 1992, 56:1034-1036.
9. Brand-Miller J.C., Holt S.H.A., Pawlak D.B., McMillan J. Glycemic index and obesity. Am. J. Clin. Nutr. 2002, 76:281s-285s.
10. Gates S.C., Sweeley C.C. Quantitative metabolic profiling based on gas chromatography. Clin. Chem. 1978, 24(10):1663-1673.
11. Zeng M., Liang Y., Li H., Wang M., Wang B., Chen X., et al. Plasma metabolic fingerprinting of childhood obesity by GC/MS in conjuction with multivariate statistical analysis. J. Pharm. Biomed. Anal. 2010, 52:265-272.
12. Kim H.J., Kim J.H., Noh S., Hur H.J., Sung M.J., Hwang J.T., et al. Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J. Proteome Res. 2010, 10:722-731.
13. Zhang A., Sun H., Wang P., Han Y., Wang X. Recent and potential developments of biofluid analyses in metabolomics. J. Proteomics. 2012, 75:1079-1088.
14. Shaham O., Wei R., Wang T.J., Ricciardi C., Lewis G.D., Vasan R.S., et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol. Syst. Biol. 2008, 4(214):1-9.
15. Serkova N.J., Jackman M., Brown J.L., Liu T., Hirose R., Roberts J.P., et al. Metabolic profiling of livers and blood from obese Zucker rats. J. Hepatol. 2006, 44:956-962.
16. Pan L., Qiu Y., Chen T., Lin J., Chi Y., Su M., et al. An optimized procedure for metabonomic analysis of rat liver tissue using gas chromatography/time-of-flight mass spectrometry. J. Pharm. Biomed. Anal. 2010, 52:589-596.
17. Spagou K., Theodoridis G., Wilson I., Raikos N., Greaves P., Edwards R., et al. A GC-MS metabolic profiling study of plasma samples from mice on low- and high-fat diets. J. Chromatogr. B. 2011, 879:1467-1475.
18. Wang C., Kong H., Guan Y., Yang J., Gu J., Yang S., et al. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal. Chem. 2005, 77:4108-4116.
19. Liu L., Aa J., Wang G., Yan B., Zhang Y., Wang X., et al. Differences in metabolite profile between blood plasma and serum. Anal. Biochem. 2010, 406:105-112.
20. Zhao T., Zhang H., Zhao T., Zhang X., Lu J., Yin T., et al. Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease. J. Pharm. Biomed. Anal. 2012, 60:32-43.
21. Peterson Z.D., Bowerbank C.R., Collins D.C., Graves S.W., Lee M.L. Advantage and limitations of coupling isotachophoresis and comprehensive isotachophoresis-capillary electrophoresis to time-of-flight mass spectrometry. J. Chromatogr. A. 2003, 992:169-179.
22. Lee S., Choi H.K., Cho S.K., Kim Y.S. Metabolic analysis of guava (Psidium guajava L.) fruits at different ripening stages using different data-processing approaches. J. Chromatogr. B. 2010, 878:2983-2988.
23. Lu H., Dunn W.B., Shen H., Kell D.B., Liang Y. Comparative evaluation of software for deconvolution of metabolomics data based on GC-TOF-MS. Trend. Anal. Chem. 2008, 27(3):215-227.
24. Jia Y., Bhuiyan M.J., Jun H.J., Lee J.H., Hoang M.H., Lee H.J., et al. Ursolic acid is a PPAR-alpha agonist that regulates hepatic lipid metabolism. Bioorg. Med. Chem. Lett. 2011, 21:5876-5880.
25. Lee J.H., Jun H.J., Hoang M.H., Jia Y., Han X.H., Lee D.H., et al. Catalposide is a natural agonistic ligand of peroxisome proliferator-activated receptor-alpha. Biochem. Biophys. Res. Commun. 2012, 422:568-572.
26. Lee J.H., Jun H.J., Jia Y., Kim W., Choi S.G., Lee S.J. Critical role of peroxisome proliferator activated receptor-delta on body fat reduction in C57BL/6J and human apolipoprotein E2 transgenic mice fed delipidated soybean. J. Agric. Food Chem. 2011, 59:11872-11881.
27. Jun H.J., Lee J.H., Jia Y., Hoang M.H., Byun H., Kim K.H., et al. Melissa officinalis essential oil reduces plasma triglycerides in human apolipoprotein E2 transgenic mice by inhibiting sterol regulatory element-binding protein-1c-dependent fatty acid synthesis. J. Nutr. 2012, 142:432-440.
28. Scribner K.B., Pawlak D.B., Ludwig D.S. Hepatic steatosis and increased adiposity in mice consuming rapidly vs. slowly absorbed carbohydrate. Obesity 2007, 15:2190-2199.
29. Lattimer J.M., Haub M.D. Effects of dietary fiber and its components on metabolic health. Nutrients 2010, 2:1266-1289.
30. Schadinger S.E., Bucher N.L., Schreiber B.M. Farmer SR (2005) PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E1195-E1205.
31. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998, 392:398-401.
32. Islam A., Civitarese A.E., Hesslink R.L., Gallaher D.D. Viscous dietary fiber reduces adiposity and plasma leptin and increases muscle expression of fat oxidation genes in rats. Obesity 2012, 20(2):398-401.
33. Prentki M., Joly E., El-Assaad W., Roduit R. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes 2002, 51(Suppl 3):S405-S413.
34. Poirier Y., Antonenkov V.D., Glumoff T., Hiltunen J.K. Peroxisomal beta-oxidation-a metabolic pathway with multiple functions. Biochim. Biophys. Acta 2006, 1763:1413-1426.
35. Ruby M.A., Goldenson B., Orasanu G., Johnston T.P., Plutzky J., Krauss R.M. VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids. J. Lipid. Res. 2010, 51:2275-2281.
36. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes. Metab. 2006, 8:264-280.
37. You M., Rogers Q. Adiponectin: a key adipokine in alcoholic fatty liver. Exp. Biol. Med. 2009, 234(8):850-859.
38. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86(5):1930-1935.
39. Kahn B.B., Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 2000, 106:473-481.
40. Ramis J.M., Bibiloni B., Moreiro J., García-Sanz J.M., Salinas R., Proenza A.M., et al. Tissue leptin and plasma insulin are associated with lipoprotein lipase activity in severely obese patients. J. Nutr. Biochem 2005, 16(5):279-285.
41. Chen N., Bezzina R., Hinch E., Lewandowski P.A., Cameron-Smith D., Mathai M.L., et al. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr. Res. 2009, 29(11):784-793.
42. Brandt J.M., Djouadi F., Kelly D.P. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 1998, 273:23786-23792.
43. Gaucher S.P., Leary J.A. Stereochemical differentiation of mannose, glucose, galactose, and talose using zinc (ΙΙ) diethylenetriamine and ESI-ion trap mass spectrometry. Anal. Chem. 1998, 70:3009-3014.
44. Alton G., Hasilik M., Niehues R., Panneerselvam K., Etchison J.R., Fana F., Freeze H.H. Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology 1998, 8(3):285-295.
45. Ou S., Kwok K.C., Li Y., Fu L. In vitro study of possible role of dietary fiber in lowering postprandial serum glucose. J. Agric. Food Chem. 2001, 49:1026-1029.
46. Madar Z., Reyzik O., Trostler N. Reduction of glucose and insulin levels in ob/ob obese mice fed soybean dietary fiber. Nutr. Res. 1985, 5(3):305-315.
47. Goddard M.S., Young G., Marcus R. The effect of amylose content on insulin and glucose responses to ingested rice. Am. J. Clin. Nutr. 1984, 39:388-392.
48. Holm G., Sullivan L., Jagenburg R., Bjorntorp P. Effects of physical training and lean body mass on plasma amino acids in man. J. Appl. Physiol 1978, 45(2):177-181.
49. Tremblay F., Lavigne C., Jacques H., Marette A. Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu. Rev. Nutr. 2007, 27:293-310.
50. Boden G., Shulman G.I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur. J. Clin. Invest. 2002, 32(3):14-23.
51. Newgard C.B., An J., Bain J.R., Muehlbauer M.J., Stevens R.D., Lien L., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009, 9:311-326.